# FDA Inspection 1237501 - Dakhil, Dr Shaker - April 26, 2024

Source: https://www.keypedia.com/records/fda_inspections/dakhil-dr-shaker/d89b6f01-2f0f-4620-ac40-e76739cd524f
Source feed: FDA_Inspections

> FDA Inspection 1237501 for Dakhil, Dr Shaker on April 26, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1237501
- Company Name: Dakhil, Dr Shaker
- Inspection Date: 2024-04-26
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1143106 - 2021-05-21](https://www.keypedia.com/records/fda_inspections/dakhil-dr-shaker/036cb993-1aea-4614-b77a-08cb367d0f16)
- [FDA Inspection 945734 - 2015-10-08](https://www.keypedia.com/records/fda_inspections/dakhil-dr-shaker/46df6c9d-43e7-45bb-8873-8fe39dcc7061)
- [FDA Inspection 771967 - 2012-03-26](https://www.keypedia.com/records/fda_inspections/dakhil-dr-shaker/23c071b2-d809-43d8-bbe3-d3721e35a63a)
- [FDA Inspection 662659 - 2010-05-13](https://www.keypedia.com/records/fda_inspections/dakhil-dr-shaker/8b30599a-427e-4fb6-a41e-d8a4512fa6db)
- [FDA Inspection 604425 - 2009-07-22](https://www.keypedia.com/records/fda_inspections/dakhil-dr-shaker/598931d0-e411-4c8e-b0e5-6796aa1823ed)

Company: https://www.keypedia.com/companies/dakhil-dr-shaker/ff880691-4af7-4e7b-ac3d-7c9c33c6bc2a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c